SCHEMBL24788937

SCHEMBL24788937

c1ccc(-c2nc(-c3cccc(-c4cccnc4)c3)cc(-c3ccc(-c4cccc5c4c4ccccc4n5-c4ccccc4)c4ccccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.36
▸ KMO O15229 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ GRM5 P41594 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ CLK4 Q9HAZ1 3/20 0.35
▸ TSHR P16473 3/20 0.35
▸ CYP2C9 P11712 3/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ABCG2 Q9UNQ0 2/20 0.35
▸ USP2 O75604 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ DHODH Q02127 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26432148 0.94 DHODH (0.41) MAPTCYP19A1ALDH1A1CYP1A2CYP3A4
SCHEMBL24788270 0.88 KDM4E (0.41) MAPTALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL17853528 0.87 DHODH (0.43) MAPTCYP19A1ALDH1A1CYP1A2CYP3A4
SCHEMBL26432100 0.87 MAPT (0.40) MAPTKMOCYP19A1GRM5ALDH1A1
SCHEMBL24787757 0.87 DHODH (0.39) MAPTKMOCYP19A1GRM5ALDH1A1
SCHEMBL24752480 0.86 DHODH (0.37) MAPTKMOCYP19A1GRM5ALDH1A1
SCHEMBL24788935 0.86 DHODH (0.37) MAPTKMOCYP19A1GRM5ALDH1A1
SCHEMBL26432077 0.86 KDM4E (0.37) MAPTALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL24788932 0.85 DHODH (0.39) MAPTKMOCYP19A1GRM5ALDH1A1
SCHEMBL24752202 0.85 DHODH (0.39) MAPTKMOCYP19A1GRM5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
EP-4101847-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, EPCAM, TMEM109 MAPT 1120/4885KMO 4084/4885CYP19A1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback